✨ Free AI Report
Becton, Dickinson and Company: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Becton, Dickinson and Company
Research Preview

Becton, Dickinson and Company: Business Overview, Financials & Competitive Analysis

Becton, Dickinson and Company (NYSE: BDX) is a leading global medical technology company. Following a reorganization effective October 1, 2025, the company operates through five segments: Medical Essentials, Connected...

Analyst-debate audio for Becton, Dickinson and Company

AskCyborg analysts argue the bull and bear cases for Becton, Dickinson and Company across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Becton, Dickinson and Company OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Diversified medical technology leader navigating post-restructuring with solid profitability but near-term margin pressure from...

Read the full analyst-debate transcript →
Industry Medical Technology & Devices
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Becton, Dickinson and Company Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Becton, Dickinson and Company Overview

Pro stress-test →

Becton, Dickinson and Company (NYSE: BDX) is a leading global medical technology company. Following a reorganization effective October 1, 2025, the company operates through five segments: Medical Essentials, Connected Care, Biopharma Systems, Interventional, and Life Sciences (Biosciences Diagnostic Solutions). BDX recently completed the spin-off of its Life Sciences & Diagnostic Solutions segment, receiving $4B to be split between debt reduction and share repurchases.

Strategic Profile

Pro stress-test →

Becton, Dickinson and Company delivered a Q1 2026 earnings beat, with $2.91 non-GAAP EPS and $5.25B revenue, surpassing expectations. New Becton, Dickinson and Company grew 2.5%, with broad-based growth across the markets where the company has been doubling down on investments. For fiscal 2026, the company continues to expect new Becton, Dickinson and Company to deliver low single-digit revenue growth.

Competitive Landscape

Pro stress-test →

Becton Dickinson competes in the global medical technology sector against established diversified healthcare companies. Primary competitors include companies like Medtronic and Abbott Laboratories in various medical device segments, alongside specialized players in diagnostics and drug delivery systems. BD maintains competitive positioning through innovation in pharmacy automation, biologic drug delivery systems, and diagnostic solutions.

Industry Context

Becton, Dickinson and Company operates in Medical Technology & Devices.

Key facts

Founded: 1897 · Headquarters: Franklin Lakes, New Jersey · Employees: ~85,000 · Revenue: $5.25B (Q1 FY2026) · Market cap: ~$88B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Becton, Dickinson and Company.

+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Becton, Dickinson and Company has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Medical Device PortfolioDiversified medical technology competitor across surgical and diagnostic segments→Healthcare SolutionsMulti-segment healthcare company competing in diagnostics and patient monitoring→Syringes & Injection SystemsGlobal healthcare company focused on medical devices and drug delivery→

Compare Becton, Dickinson and Company with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Becton, Dickinson and Company operates in Medical Technology & Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Technology & Devices research →
NEW · MCP server

Ask your AI assistant about Becton, Dickinson and Company

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Becton, Dickinson and Company and its top competitor on Cyborg Score”
“What did Becton, Dickinson and Company do this quarter?”
“Is Becton, Dickinson and Company a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Becton, Dickinson and Company do?+
Becton, Dickinson and Company (NYSE: BDX) is a leading global medical technology company. Following a reorganization effective October 1, 2025, the company operates through five segments: Medical Essentials, Connected...
What is Becton, Dickinson and Company's Cyborg Score?+
Becton, Dickinson and Company has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Becton, Dickinson and Company's main competitors?+
Named competitors include Medical Device Portfolio, Healthcare Solutions, Syringes & Injection Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full Becton, Dickinson and Company research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Becton, Dickinson and Company research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Becton, Dickinson and Company over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.